PRMT5 and neoplasm: PRMT5 was first characterized as a transcriptional repressor by catalyzing the symmetric dimethylation of histone H3 arginine 8 (H3R8) and H4 arginine 3 (H4R3), leading to transcriptional repression of tumor-suppressor genes [14].